nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—ovarian follicle—hematologic cancer	0.128	0.661	CbGeAlD
Tranexamic Acid—PLG—hematopoietic system—hematologic cancer	0.0154	0.0798	CbGeAlD
Tranexamic Acid—PLG—gonad—hematologic cancer	0.0117	0.0607	CbGeAlD
Tranexamic Acid—PLG—blood—hematologic cancer	0.0102	0.0528	CbGeAlD
Tranexamic Acid—PLG—lung—hematologic cancer	0.00895	0.0463	CbGeAlD
Tranexamic Acid—PLG—testis—hematologic cancer	0.00844	0.0437	CbGeAlD
Tranexamic Acid—SLC15A2—blood—hematologic cancer	0.00326	0.0169	CbGeAlD
Tranexamic Acid—SLC15A2—lung—hematologic cancer	0.00286	0.0148	CbGeAlD
Tranexamic Acid—SLC15A2—testis—hematologic cancer	0.0027	0.014	CbGeAlD
Tranexamic Acid—SLC15A2—lymph node—hematologic cancer	0.00196	0.0101	CbGeAlD
Tranexamic Acid—PLG—Metabolism of proteins—SPHK1—hematologic cancer	0.000323	0.00114	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	0.000322	0.00114	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000322	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—hematologic cancer	0.00032	0.00113	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SPARC—hematologic cancer	0.000318	0.00112	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000314	0.00111	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PPEF1—hematologic cancer	0.000313	0.0011	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FN1—hematologic cancer	0.000312	0.0011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAP2K1—hematologic cancer	0.000309	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—LCK—hematologic cancer	0.000308	0.00109	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CD—hematologic cancer	0.000307	0.00108	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000304	0.00107	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000303	0.00107	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000302	0.00107	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—H3F3A—hematologic cancer	0.000302	0.00106	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—PDGFB—hematologic cancer	0.0003	0.00106	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GATA3—hematologic cancer	0.000299	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	0.000299	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HSPA5—hematologic cancer	0.000298	0.00105	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000296	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—FGF2—hematologic cancer	0.000294	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCZ—hematologic cancer	0.000294	0.00103	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3R1—hematologic cancer	0.00029	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPS14—hematologic cancer	0.00029	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—AKT1—hematologic cancer	0.000289	0.00102	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000287	0.00101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—JAK2—hematologic cancer	0.000281	0.000992	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MDM2—hematologic cancer	0.000275	0.000968	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HDAC2—hematologic cancer	0.000274	0.000964	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FN1—hematologic cancer	0.000271	0.000954	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITGA4—hematologic cancer	0.00027	0.000953	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CD44—hematologic cancer	0.00027	0.000953	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—ICAM1—hematologic cancer	0.00027	0.00095	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CB—hematologic cancer	0.000267	0.000942	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MTOR—hematologic cancer	0.000267	0.000942	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000264	0.00093	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL3—hematologic cancer	0.000264	0.00093	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	0.000263	0.000925	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000262	0.000925	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000262	0.000925	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000262	0.000925	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNA1—hematologic cancer	0.000262	0.000923	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PTPN1—hematologic cancer	0.000259	0.000914	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ALB—hematologic cancer	0.000259	0.000913	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—hematologic cancer	0.000258	0.000909	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RASGRP1—hematologic cancer	0.000255	0.000899	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SYK—hematologic cancer	0.000254	0.000896	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EIF4EBP1—hematologic cancer	0.000253	0.000892	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—hematologic cancer	0.000251	0.000884	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	0.000248	0.000874	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HDAC11—hematologic cancer	0.000248	0.000873	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IFNA2—hematologic cancer	0.000244	0.000859	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	0.000241	0.000849	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BCR—hematologic cancer	0.000238	0.000837	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000236	0.000833	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSPA5—hematologic cancer	0.000234	0.000825	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1A—hematologic cancer	0.000231	0.000816	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—hematologic cancer	0.000231	0.000814	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GRB2—hematologic cancer	0.000229	0.000809	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PDGFA—hematologic cancer	0.000229	0.000807	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	0.000229	0.000806	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CALR—hematologic cancer	0.000227	0.0008	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000222	0.000781	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HDAC10—hematologic cancer	0.000221	0.000778	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ABL1—hematologic cancer	0.00022	0.000777	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—FBXW7—hematologic cancer	0.000219	0.000773	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGF2—hematologic cancer	0.000218	0.000768	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SRC—hematologic cancer	0.000214	0.000755	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—hematologic cancer	0.00021	0.000741	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000207	0.000731	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HGF—hematologic cancer	0.000207	0.000731	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—STAT3—hematologic cancer	0.000207	0.000728	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—NRAS—hematologic cancer	0.000206	0.000726	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CSF2—hematologic cancer	0.000205	0.000722	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ARHGEF12—hematologic cancer	0.000202	0.000712	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PRKCG—hematologic cancer	0.000198	0.000697	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—JAK1—hematologic cancer	0.000198	0.000697	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—hematologic cancer	0.000197	0.000696	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ARHGEF1—hematologic cancer	0.000197	0.000694	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.00019	0.000669	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000185	0.000652	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2RA—hematologic cancer	0.000185	0.000651	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—SRC—hematologic cancer	0.000183	0.000646	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CASP3—hematologic cancer	0.000183	0.000643	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.000179	0.000631	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	0.000179	0.000629	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PDGFB—hematologic cancer	0.000178	0.000628	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—hematologic cancer	0.000177	0.000625	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGRN—hematologic cancer	0.000177	0.000622	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL17—hematologic cancer	0.000177	0.000622	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000174	0.000613	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR5—hematologic cancer	0.000173	0.000611	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CDK2—hematologic cancer	0.000173	0.00061	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000173	0.000608	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEF1—hematologic cancer	0.00017	0.0006	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000169	0.000596	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	0.000169	0.000595	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GNA13—hematologic cancer	0.000167	0.00059	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MAPK14—hematologic cancer	0.000166	0.000585	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TIAM1—hematologic cancer	0.000165	0.00058	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	0.000164	0.000578	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—hematologic cancer	0.000163	0.000574	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FN1—hematologic cancer	0.000161	0.000567	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAK3—hematologic cancer	0.00016	0.000563	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CG—hematologic cancer	0.000154	0.000543	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCR7—hematologic cancer	0.000153	0.000539	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCL13—hematologic cancer	0.000153	0.000539	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PTPN11—hematologic cancer	0.000151	0.000533	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NCOR2—hematologic cancer	0.000151	0.000532	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—HRAS—hematologic cancer	0.000151	0.000531	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000151	0.000531	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CRKL—hematologic cancer	0.000149	0.000526	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL3RA—hematologic cancer	0.000149	0.000526	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—hematologic cancer	0.000144	0.000509	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RGS2—hematologic cancer	0.000144	0.000507	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CREBBP—hematologic cancer	0.000143	0.000503	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TRH—hematologic cancer	0.000142	0.000502	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TRIO—hematologic cancer	0.000142	0.000502	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CMA1—hematologic cancer	0.000142	0.000502	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—hematologic cancer	0.000142	0.000501	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	0.000139	0.000492	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AGO2—hematologic cancer	0.000139	0.000491	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPHK1—hematologic cancer	0.000139	0.000491	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LPAR1—hematologic cancer	0.000138	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HDAC9—hematologic cancer	0.000138	0.000486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—H3F3B—hematologic cancer	0.000136	0.000481	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CD—hematologic cancer	0.000135	0.000477	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ALB—hematologic cancer	0.000134	0.000471	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—AKT1—hematologic cancer	0.000133	0.000469	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.00013	0.000458	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3R1—hematologic cancer	0.000128	0.00045	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDE4B—hematologic cancer	0.000127	0.000447	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CNR2—hematologic cancer	0.000127	0.000447	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000126	0.000446	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF19—hematologic cancer	0.000126	0.000443	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAC2—hematologic cancer	0.000125	0.00044	CbGpPWpGaD
Tranexamic Acid—Convulsion—Betamethasone—hematologic cancer	0.000125	0.000238	CcSEcCtD
Tranexamic Acid—Convulsion—Dexamethasone—hematologic cancer	0.000125	0.000238	CcSEcCtD
Tranexamic Acid—Headache—Thiotepa—hematologic cancer	0.000125	0.000238	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—JAK2—hematologic cancer	0.000124	0.000438	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DKK1—hematologic cancer	0.000124	0.000436	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Ifosfamide—hematologic cancer	0.000124	0.000236	CcSEcCtD
Tranexamic Acid—Nausea—Vinorelbine—hematologic cancer	0.000124	0.000236	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—CREBBP—hematologic cancer	0.000124	0.000435	CbGpPWpGaD
Tranexamic Acid—Renal failure—Epirubicin—hematologic cancer	0.000123	0.000236	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000123	0.000236	CcSEcCtD
Tranexamic Acid—Asthenia—Mitoxantrone—hematologic cancer	0.000123	0.000235	CcSEcCtD
Tranexamic Acid—Asthenia—Irinotecan—hematologic cancer	0.000123	0.000235	CcSEcCtD
Tranexamic Acid—Fatigue—Etoposide—hematologic cancer	0.000123	0.000235	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—STAT5B—hematologic cancer	0.000123	0.000433	CbGpPWpGaD
Tranexamic Acid—Myalgia—Betamethasone—hematologic cancer	0.000123	0.000234	CcSEcCtD
Tranexamic Acid—Myalgia—Dexamethasone—hematologic cancer	0.000123	0.000234	CcSEcCtD
Tranexamic Acid—Vomiting—Thalidomide—hematologic cancer	0.000122	0.000234	CcSEcCtD
Tranexamic Acid—Dizziness—Carmustine—hematologic cancer	0.000122	0.000233	CcSEcCtD
Tranexamic Acid—Discomfort—Betamethasone—hematologic cancer	0.000121	0.000232	CcSEcCtD
Tranexamic Acid—Discomfort—Dexamethasone—hematologic cancer	0.000121	0.000232	CcSEcCtD
Tranexamic Acid—Haemoglobin—Methotrexate—hematologic cancer	0.000121	0.000231	CcSEcCtD
Tranexamic Acid—Dizziness—Alitretinoin—hematologic cancer	0.000121	0.000231	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vincristine—hematologic cancer	0.000121	0.000231	CcSEcCtD
Tranexamic Acid—Headache—Thalidomide—hematologic cancer	0.00012	0.00023	CcSEcCtD
Tranexamic Acid—Haemorrhage—Methotrexate—hematologic cancer	0.00012	0.00023	CcSEcCtD
Tranexamic Acid—Asthenia—Gemcitabine—hematologic cancer	0.00012	0.000229	CcSEcCtD
Tranexamic Acid—Dizziness—Ifosfamide—hematologic cancer	0.00012	0.000229	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ADCY7—hematologic cancer	0.000119	0.00042	CbGpPWpGaD
Tranexamic Acid—Nausea—Thiotepa—hematologic cancer	0.000118	0.000226	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	0.000118	0.000226	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CB—hematologic cancer	0.000118	0.000416	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Epirubicin—hematologic cancer	0.000118	0.000225	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etoposide—hematologic cancer	0.000118	0.000225	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000118	0.000225	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Betamethasone—hematologic cancer	0.000118	0.000225	CcSEcCtD
Tranexamic Acid—Diarrhoea—Irinotecan—hematologic cancer	0.000117	0.000225	CcSEcCtD
Tranexamic Acid—Diarrhoea—Mitoxantrone—hematologic cancer	0.000117	0.000225	CcSEcCtD
Tranexamic Acid—Vomiting—Carmustine—hematologic cancer	0.000117	0.000224	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etoposide—hematologic cancer	0.000117	0.000223	CcSEcCtD
Tranexamic Acid—Dizziness—Vincristine—hematologic cancer	0.000117	0.000223	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Prednisone—hematologic cancer	0.000116	0.000222	CcSEcCtD
Tranexamic Acid—Vomiting—Alitretinoin—hematologic cancer	0.000116	0.000222	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Prednisolone—hematologic cancer	0.000116	0.000222	CcSEcCtD
Tranexamic Acid—Visual impairment—Methotrexate—hematologic cancer	0.000116	0.000222	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—XIAP—hematologic cancer	0.000116	0.000409	CbGpPWpGaD
Tranexamic Acid—Anaemia—Prednisone—hematologic cancer	0.000116	0.000222	CcSEcCtD
Tranexamic Acid—Headache—Carmustine—hematologic cancer	0.000116	0.000221	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ALB—hematologic cancer	0.000116	0.000408	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Triamcinolone—hematologic cancer	0.000115	0.000221	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Dexamethasone—hematologic cancer	0.000115	0.00022	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Betamethasone—hematologic cancer	0.000115	0.00022	CcSEcCtD
Tranexamic Acid—Vomiting—Ifosfamide—hematologic cancer	0.000115	0.00022	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Cisplatin—hematologic cancer	0.000115	0.00022	CcSEcCtD
Tranexamic Acid—Headache—Alitretinoin—hematologic cancer	0.000115	0.000219	CcSEcCtD
Tranexamic Acid—Diarrhoea—Gemcitabine—hematologic cancer	0.000114	0.000219	CcSEcCtD
Tranexamic Acid—Nausea—Thalidomide—hematologic cancer	0.000114	0.000218	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—hematologic cancer	0.000114	0.000218	CcSEcCtD
Tranexamic Acid—Dyspepsia—Triamcinolone—hematologic cancer	0.000114	0.000218	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	0.000114	0.000402	CbGpPWpGaD
Tranexamic Acid—Dizziness—Irinotecan—hematologic cancer	0.000114	0.000217	CcSEcCtD
Tranexamic Acid—Haemoglobin—Epirubicin—hematologic cancer	0.000113	0.000216	CcSEcCtD
Tranexamic Acid—Malaise—Prednisone—hematologic cancer	0.000113	0.000216	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SH2B3—hematologic cancer	0.000113	0.000398	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SMARCA4—hematologic cancer	0.000113	0.000398	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Etoposide—hematologic cancer	0.000113	0.000216	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—CCL2—hematologic cancer	0.000113	0.000397	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Epirubicin—hematologic cancer	0.000113	0.000215	CcSEcCtD
Tranexamic Acid—Eye disorder—Methotrexate—hematologic cancer	0.000113	0.000215	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GZMB—hematologic cancer	0.000112	0.000396	CbGpPWpGaD
Tranexamic Acid—Vomiting—Vincristine—hematologic cancer	0.000112	0.000214	CcSEcCtD
Tranexamic Acid—Asthenia—Cisplatin—hematologic cancer	0.000112	0.000214	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Methotrexate—hematologic cancer	0.000112	0.000214	CcSEcCtD
Tranexamic Acid—Fatigue—Triamcinolone—hematologic cancer	0.000112	0.000213	CcSEcCtD
Tranexamic Acid—Headache—Vincristine—hematologic cancer	0.00011	0.000211	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Prednisone—hematologic cancer	0.00011	0.000211	CcSEcCtD
Tranexamic Acid—Hypotension—Betamethasone—hematologic cancer	0.00011	0.00021	CcSEcCtD
Tranexamic Acid—Hypotension—Dexamethasone—hematologic cancer	0.00011	0.00021	CcSEcCtD
Tranexamic Acid—Nausea—Carmustine—hematologic cancer	0.00011	0.00021	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CTNNA1—hematologic cancer	0.00011	0.000387	CbGpPWpGaD
Tranexamic Acid—Angiopathy—Methotrexate—hematologic cancer	0.000109	0.000209	CcSEcCtD
Tranexamic Acid—Vomiting—Mitoxantrone—hematologic cancer	0.000109	0.000209	CcSEcCtD
Tranexamic Acid—Vomiting—Irinotecan—hematologic cancer	0.000109	0.000209	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HSPB1—hematologic cancer	0.000109	0.000384	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000109	0.000384	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCL3—hematologic cancer	0.000109	0.000384	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Doxorubicin—hematologic cancer	0.000109	0.000208	CcSEcCtD
Tranexamic Acid—Immune system disorder—Methotrexate—hematologic cancer	0.000109	0.000208	CcSEcCtD
Tranexamic Acid—Nausea—Alitretinoin—hematologic cancer	0.000109	0.000208	CcSEcCtD
Tranexamic Acid—Convulsion—Prednisone—hematologic cancer	0.000109	0.000208	CcSEcCtD
Tranexamic Acid—Visual impairment—Epirubicin—hematologic cancer	0.000109	0.000208	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Methotrexate—hematologic cancer	0.000109	0.000207	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IL2—hematologic cancer	0.000108	0.000382	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTHLH—hematologic cancer	0.000108	0.00038	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SDC1—hematologic cancer	0.000108	0.00038	CbGpPWpGaD
Tranexamic Acid—Headache—Irinotecan—hematologic cancer	0.000108	0.000206	CcSEcCtD
Tranexamic Acid—Headache—Mitoxantrone—hematologic cancer	0.000108	0.000206	CcSEcCtD
Tranexamic Acid—Nausea—Ifosfamide—hematologic cancer	0.000107	0.000205	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Betamethasone—hematologic cancer	0.000107	0.000205	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	0.000107	0.000205	CcSEcCtD
Tranexamic Acid—Myalgia—Prednisone—hematologic cancer	0.000107	0.000204	CcSEcCtD
Tranexamic Acid—Arthralgia—Prednisone—hematologic cancer	0.000107	0.000204	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Triamcinolone—hematologic cancer	0.000107	0.000204	CcSEcCtD
Tranexamic Acid—Diarrhoea—Cisplatin—hematologic cancer	0.000107	0.000204	CcSEcCtD
Tranexamic Acid—Vomiting—Gemcitabine—hematologic cancer	0.000106	0.000203	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000106	0.000372	CbGpPWpGaD
Tranexamic Acid—Discomfort—Prednisone—hematologic cancer	0.000105	0.000202	CcSEcCtD
Tranexamic Acid—Eye disorder—Epirubicin—hematologic cancer	0.000105	0.000201	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etoposide—hematologic cancer	0.000105	0.000201	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTGER4—hematologic cancer	0.000105	0.00037	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Doxorubicin—hematologic cancer	0.000105	0.0002	CcSEcCtD
Tranexamic Acid—Headache—Gemcitabine—hematologic cancer	0.000105	0.0002	CcSEcCtD
Tranexamic Acid—Nausea—Vincristine—hematologic cancer	0.000105	0.0002	CcSEcCtD
Tranexamic Acid—Flushing—Epirubicin—hematologic cancer	0.000105	0.0002	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Epirubicin—hematologic cancer	0.000105	0.0002	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LCK—hematologic cancer	0.000104	0.000368	CbGpPWpGaD
Tranexamic Acid—Haemorrhage—Doxorubicin—hematologic cancer	0.000104	0.000199	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Prednisolone—hematologic cancer	0.000104	0.000198	CcSEcCtD
Tranexamic Acid—Dyspepsia—Dexamethasone—hematologic cancer	0.000103	0.000198	CcSEcCtD
Tranexamic Acid—Dyspepsia—Betamethasone—hematologic cancer	0.000103	0.000198	CcSEcCtD
Tranexamic Acid—Asthenia—Etoposide—hematologic cancer	0.000102	0.000196	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—H3F3A—hematologic cancer	0.000102	0.000361	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Prednisone—hematologic cancer	0.000102	0.000196	CcSEcCtD
Tranexamic Acid—Angiopathy—Epirubicin—hematologic cancer	0.000102	0.000195	CcSEcCtD
Tranexamic Acid—Nausea—Irinotecan—hematologic cancer	0.000102	0.000195	CcSEcCtD
Tranexamic Acid—Nausea—Mitoxantrone—hematologic cancer	0.000102	0.000195	CcSEcCtD
Tranexamic Acid—Immune system disorder—Epirubicin—hematologic cancer	0.000102	0.000195	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Epirubicin—hematologic cancer	0.000102	0.000194	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000101	0.000194	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000101	0.000194	CcSEcCtD
Tranexamic Acid—Back pain—Methotrexate—hematologic cancer	0.000101	0.000194	CcSEcCtD
Tranexamic Acid—Fatigue—Betamethasone—hematologic cancer	0.000101	0.000194	CcSEcCtD
Tranexamic Acid—Fatigue—Dexamethasone—hematologic cancer	0.000101	0.000194	CcSEcCtD
Tranexamic Acid—Arrhythmia—Epirubicin—hematologic cancer	0.000101	0.000192	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—hematologic cancer	0.0001	0.000192	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Prednisone—hematologic cancer	0.0001	0.000192	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PRKCZ—hematologic cancer	9.95e-05	0.000351	CbGpPWpGaD
Tranexamic Acid—Nausea—Gemcitabine—hematologic cancer	9.93e-05	0.00019	CcSEcCtD
Tranexamic Acid—Vomiting—Cisplatin—hematologic cancer	9.91e-05	0.000189	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etoposide—hematologic cancer	9.77e-05	0.000187	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—hematologic cancer	9.74e-05	0.000186	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Methotrexate—hematologic cancer	9.73e-05	0.000186	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—EP300—hematologic cancer	9.72e-05	0.000343	CbGpPWpGaD
Tranexamic Acid—Anaemia—Methotrexate—hematologic cancer	9.69e-05	0.000185	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Dexamethasone—hematologic cancer	9.69e-05	0.000185	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Betamethasone—hematologic cancer	9.69e-05	0.000185	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—hematologic cancer	9.68e-05	0.000185	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—hematologic cancer	9.68e-05	0.000185	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PARP1—hematologic cancer	9.61e-05	0.000339	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	9.61e-05	0.000184	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	9.61e-05	0.000184	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Triamcinolone—hematologic cancer	9.54e-05	0.000182	CcSEcCtD
Tranexamic Acid—Back pain—Epirubicin—hematologic cancer	9.49e-05	0.000181	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—hematologic cancer	9.46e-05	0.000181	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FBXW7—hematologic cancer	9.46e-05	0.000333	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—SRC—hematologic cancer	9.45e-05	0.000333	CbGpPWpGaD
Tranexamic Acid—Malaise—Methotrexate—hematologic cancer	9.45e-05	0.000181	CcSEcCtD
Tranexamic Acid—Dizziness—Etoposide—hematologic cancer	9.44e-05	0.000181	CcSEcCtD
Tranexamic Acid—Muscle spasms—Epirubicin—hematologic cancer	9.43e-05	0.00018	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—hematologic cancer	9.42e-05	0.00018	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—hematologic cancer	9.4e-05	0.00018	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Prednisone—hematologic cancer	9.33e-05	0.000178	CcSEcCtD
Tranexamic Acid—Dizziness—Prednisolone—hematologic cancer	9.31e-05	0.000178	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—hematologic cancer	9.31e-05	0.000178	CcSEcCtD
Tranexamic Acid—Asthenia—Triamcinolone—hematologic cancer	9.29e-05	0.000178	CcSEcCtD
Tranexamic Acid—Abdominal pain—Betamethasone—hematologic cancer	9.29e-05	0.000178	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dexamethasone—hematologic cancer	9.29e-05	0.000178	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HDAC2—hematologic cancer	9.27e-05	0.000327	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CXCR4—hematologic cancer	9.27e-05	0.000327	CbGpPWpGaD
Tranexamic Acid—Nausea—Cisplatin—hematologic cancer	9.26e-05	0.000177	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFA—hematologic cancer	9.21e-05	0.000324	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Epirubicin—hematologic cancer	9.1e-05	0.000174	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—NRAS—hematologic cancer	9.09e-05	0.00032	CbGpPWpGaD
Tranexamic Acid—Convulsion—Methotrexate—hematologic cancer	9.08e-05	0.000174	CcSEcCtD
Tranexamic Acid—Vomiting—Etoposide—hematologic cancer	9.08e-05	0.000174	CcSEcCtD
Tranexamic Acid—Anaemia—Epirubicin—hematologic cancer	9.07e-05	0.000173	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CBL—hematologic cancer	9.04e-05	0.000319	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Prednisone—hematologic cancer	9.01e-05	0.000172	CcSEcCtD
Tranexamic Acid—Headache—Etoposide—hematologic cancer	8.95e-05	0.000171	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IL3—hematologic cancer	8.94e-05	0.000315	CbGpPWpGaD
Tranexamic Acid—Myalgia—Methotrexate—hematologic cancer	8.92e-05	0.000171	CcSEcCtD
Tranexamic Acid—Arthralgia—Methotrexate—hematologic cancer	8.92e-05	0.000171	CcSEcCtD
Tranexamic Acid—Chest pain—Methotrexate—hematologic cancer	8.92e-05	0.000171	CcSEcCtD
Tranexamic Acid—Malaise—Epirubicin—hematologic cancer	8.85e-05	0.000169	CcSEcCtD
Tranexamic Acid—Fatigue—Prednisone—hematologic cancer	8.82e-05	0.000169	CcSEcCtD
Tranexamic Acid—Headache—Prednisolone—hematologic cancer	8.82e-05	0.000169	CcSEcCtD
Tranexamic Acid—Discomfort—Methotrexate—hematologic cancer	8.82e-05	0.000169	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTPN1—hematologic cancer	8.79e-05	0.00031	CbGpPWpGaD
Tranexamic Acid—Back pain—Doxorubicin—hematologic cancer	8.78e-05	0.000168	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—hematologic cancer	8.73e-05	0.000167	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK3—hematologic cancer	8.71e-05	0.000307	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RASGRP1—hematologic cancer	8.65e-05	0.000305	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HSP90AA1—hematologic cancer	8.62e-05	0.000304	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SYK—hematologic cancer	8.62e-05	0.000304	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Epirubicin—hematologic cancer	8.62e-05	0.000165	CcSEcCtD
Tranexamic Acid—Dizziness—Triamcinolone—hematologic cancer	8.57e-05	0.000164	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Methotrexate—hematologic cancer	8.55e-05	0.000164	CcSEcCtD
Tranexamic Acid—Convulsion—Epirubicin—hematologic cancer	8.5e-05	0.000162	CcSEcCtD
Tranexamic Acid—Nausea—Etoposide—hematologic cancer	8.48e-05	0.000162	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TGFB1—hematologic cancer	8.45e-05	0.000298	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Prednisone—hematologic cancer	8.43e-05	0.000161	CcSEcCtD
Tranexamic Acid—Asthenia—Dexamethasone—hematologic cancer	8.43e-05	0.000161	CcSEcCtD
Tranexamic Acid—Asthenia—Betamethasone—hematologic cancer	8.43e-05	0.000161	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—hematologic cancer	8.42e-05	0.000161	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Methotrexate—hematologic cancer	8.39e-05	0.00016	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—hematologic cancer	8.39e-05	0.00016	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Prednisone—hematologic cancer	8.37e-05	0.00016	CcSEcCtD
Tranexamic Acid—Nausea—Prednisolone—hematologic cancer	8.37e-05	0.00016	CcSEcCtD
Tranexamic Acid—Chest pain—Epirubicin—hematologic cancer	8.35e-05	0.00016	CcSEcCtD
Tranexamic Acid—Myalgia—Epirubicin—hematologic cancer	8.35e-05	0.00016	CcSEcCtD
Tranexamic Acid—Arthralgia—Epirubicin—hematologic cancer	8.35e-05	0.00016	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—STAT1—hematologic cancer	8.31e-05	0.000293	CbGpPWpGaD
Tranexamic Acid—Discomfort—Epirubicin—hematologic cancer	8.25e-05	0.000158	CcSEcCtD
Tranexamic Acid—Vomiting—Triamcinolone—hematologic cancer	8.24e-05	0.000157	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—hematologic cancer	8.18e-05	0.000156	CcSEcCtD
Tranexamic Acid—Headache—Triamcinolone—hematologic cancer	8.11e-05	0.000155	CcSEcCtD
Tranexamic Acid—Abdominal pain—Prednisone—hematologic cancer	8.09e-05	0.000155	CcSEcCtD
Tranexamic Acid—Diarrhoea—Betamethasone—hematologic cancer	8.04e-05	0.000154	CcSEcCtD
Tranexamic Acid—Diarrhoea—Dexamethasone—hematologic cancer	8.04e-05	0.000154	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Epirubicin—hematologic cancer	8.01e-05	0.000153	CcSEcCtD
Tranexamic Acid—Hypotension—Methotrexate—hematologic cancer	7.99e-05	0.000153	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—hematologic cancer	7.98e-05	0.000152	CcSEcCtD
Tranexamic Acid—Convulsion—Doxorubicin—hematologic cancer	7.86e-05	0.00015	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Epirubicin—hematologic cancer	7.85e-05	0.00015	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KRAS—hematologic cancer	7.83e-05	0.000276	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Methotrexate—hematologic cancer	7.79e-05	0.000149	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GRB2—hematologic cancer	7.78e-05	0.000274	CbGpPWpGaD
Tranexamic Acid—Dizziness—Dexamethasone—hematologic cancer	7.77e-05	0.000149	CcSEcCtD
Tranexamic Acid—Dizziness—Betamethasone—hematologic cancer	7.77e-05	0.000149	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PDGFA—hematologic cancer	7.76e-05	0.000273	CbGpPWpGaD
Tranexamic Acid—Chest pain—Doxorubicin—hematologic cancer	7.73e-05	0.000148	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—hematologic cancer	7.73e-05	0.000148	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—hematologic cancer	7.73e-05	0.000148	CcSEcCtD
Tranexamic Acid—Nausea—Triamcinolone—hematologic cancer	7.69e-05	0.000147	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—KITLG—hematologic cancer	7.65e-05	0.00027	CbGpPWpGaD
Tranexamic Acid—Discomfort—Doxorubicin—hematologic cancer	7.63e-05	0.000146	CcSEcCtD
Tranexamic Acid—Dyspnoea—Methotrexate—hematologic cancer	7.63e-05	0.000146	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Prednisone—hematologic cancer	7.54e-05	0.000144	CcSEcCtD
Tranexamic Acid—Dyspepsia—Methotrexate—hematologic cancer	7.53e-05	0.000144	CcSEcCtD
Tranexamic Acid—Hypotension—Epirubicin—hematologic cancer	7.48e-05	0.000143	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—STAT5A—hematologic cancer	7.48e-05	0.000263	CbGpPWpGaD
Tranexamic Acid—Vomiting—Dexamethasone—hematologic cancer	7.47e-05	0.000143	CcSEcCtD
Tranexamic Acid—Vomiting—Betamethasone—hematologic cancer	7.47e-05	0.000143	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—hematologic cancer	7.41e-05	0.000261	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—hematologic cancer	7.41e-05	0.000142	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	7.39e-05	0.000141	CcSEcCtD
Tranexamic Acid—Fatigue—Methotrexate—hematologic cancer	7.38e-05	0.000141	CcSEcCtD
Tranexamic Acid—Headache—Betamethasone—hematologic cancer	7.36e-05	0.000141	CcSEcCtD
Tranexamic Acid—Headache—Dexamethasone—hematologic cancer	7.36e-05	0.000141	CcSEcCtD
Tranexamic Acid—Asthenia—Prednisone—hematologic cancer	7.34e-05	0.00014	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Epirubicin—hematologic cancer	7.29e-05	0.000139	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—hematologic cancer	7.26e-05	0.000139	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—hematologic cancer	7.19e-05	0.000253	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CD86—hematologic cancer	7.17e-05	0.000253	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Epirubicin—hematologic cancer	7.14e-05	0.000136	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—HES1—hematologic cancer	7.07e-05	0.000249	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	7.05e-05	0.000249	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Methotrexate—hematologic cancer	7.05e-05	0.000135	CcSEcCtD
Tranexamic Acid—Dyspepsia—Epirubicin—hematologic cancer	7.05e-05	0.000135	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—NCOR1—hematologic cancer	7.03e-05	0.000248	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Prednisone—hematologic cancer	7e-05	0.000134	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	7e-05	0.000134	CcSEcCtD
Tranexamic Acid—Nausea—Betamethasone—hematologic cancer	6.98e-05	0.000133	CcSEcCtD
Tranexamic Acid—Nausea—Dexamethasone—hematologic cancer	6.98e-05	0.000133	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TP53—hematologic cancer	6.96e-05	0.000245	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGF1—hematologic cancer	6.95e-05	0.000245	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CSF2—hematologic cancer	6.95e-05	0.000245	CbGpPWpGaD
Tranexamic Acid—Hypotension—Doxorubicin—hematologic cancer	6.92e-05	0.000132	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	6.91e-05	0.000132	CcSEcCtD
Tranexamic Acid—Fatigue—Epirubicin—hematologic cancer	6.9e-05	0.000132	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FOXO1—hematologic cancer	6.85e-05	0.000241	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PDGFRB—hematologic cancer	6.84e-05	0.000241	CbGpPWpGaD
Tranexamic Acid—Dizziness—Prednisone—hematologic cancer	6.77e-05	0.000129	CcSEcCtD
Tranexamic Acid—Abdominal pain—Methotrexate—hematologic cancer	6.76e-05	0.000129	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	6.75e-05	0.000129	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PDGFRA—hematologic cancer	6.73e-05	0.000237	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PRKCG—hematologic cancer	6.71e-05	0.000236	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAK1—hematologic cancer	6.71e-05	0.000236	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—HRAS—hematologic cancer	6.65e-05	0.000234	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—hematologic cancer	6.6e-05	0.000126	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	6.6e-05	0.000233	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Epirubicin—hematologic cancer	6.6e-05	0.000126	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	6.55e-05	0.000125	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—hematologic cancer	6.52e-05	0.000125	CcSEcCtD
Tranexamic Acid—Vomiting—Prednisone—hematologic cancer	6.51e-05	0.000124	CcSEcCtD
Tranexamic Acid—Headache—Prednisone—hematologic cancer	6.41e-05	0.000123	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.39e-05	0.000122	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—hematologic cancer	6.39e-05	0.000122	CcSEcCtD
Tranexamic Acid—Abdominal pain—Epirubicin—hematologic cancer	6.33e-05	0.000121	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Methotrexate—hematologic cancer	6.3e-05	0.00012	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IL2RA—hematologic cancer	6.26e-05	0.000221	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TERT—hematologic cancer	6.19e-05	0.000218	CbGpPWpGaD
Tranexamic Acid—Asthenia—Methotrexate—hematologic cancer	6.14e-05	0.000117	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—hematologic cancer	6.1e-05	0.000117	CcSEcCtD
Tranexamic Acid—Nausea—Prednisone—hematologic cancer	6.08e-05	0.000116	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.06e-05	0.000116	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PDGFB—hematologic cancer	6.05e-05	0.000213	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TSC2—hematologic cancer	5.91e-05	0.000208	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Epirubicin—hematologic cancer	5.9e-05	0.000113	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—AKT1—hematologic cancer	5.87e-05	0.000207	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Doxorubicin—hematologic cancer	5.86e-05	0.000112	CcSEcCtD
Tranexamic Acid—Diarrhoea—Methotrexate—hematologic cancer	5.85e-05	0.000112	CcSEcCtD
Tranexamic Acid—Asthenia—Epirubicin—hematologic cancer	5.74e-05	0.00011	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FGFR3—hematologic cancer	5.68e-05	0.0002	CbGpPWpGaD
Tranexamic Acid—Dizziness—Methotrexate—hematologic cancer	5.66e-05	0.000108	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—MAPK14—hematologic cancer	5.63e-05	0.000198	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—hematologic cancer	5.52e-05	0.000195	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Epirubicin—hematologic cancer	5.48e-05	0.000105	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Doxorubicin—hematologic cancer	5.46e-05	0.000104	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FN1—hematologic cancer	5.45e-05	0.000192	CbGpPWpGaD
Tranexamic Acid—Vomiting—Methotrexate—hematologic cancer	5.44e-05	0.000104	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—BAD—hematologic cancer	5.39e-05	0.00019	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NFKBIA—hematologic cancer	5.39e-05	0.00019	CbGpPWpGaD
Tranexamic Acid—Headache—Methotrexate—hematologic cancer	5.36e-05	0.000102	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—NOTCH1—hematologic cancer	5.34e-05	0.000188	CbGpPWpGaD
Tranexamic Acid—Asthenia—Doxorubicin—hematologic cancer	5.31e-05	0.000102	CcSEcCtD
Tranexamic Acid—Dizziness—Epirubicin—hematologic cancer	5.29e-05	0.000101	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CD80—hematologic cancer	5.23e-05	0.000184	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—hematologic cancer	5.22e-05	0.000184	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CG—hematologic cancer	5.22e-05	0.000184	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTPN11—hematologic cancer	5.13e-05	0.000181	CbGpPWpGaD
Tranexamic Acid—Vomiting—Epirubicin—hematologic cancer	5.09e-05	9.73e-05	CcSEcCtD
Tranexamic Acid—Nausea—Methotrexate—hematologic cancer	5.08e-05	9.71e-05	CcSEcCtD
Tranexamic Acid—Diarrhoea—Doxorubicin—hematologic cancer	5.07e-05	9.69e-05	CcSEcCtD
Tranexamic Acid—Headache—Epirubicin—hematologic cancer	5.02e-05	9.59e-05	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CREB1—hematologic cancer	4.97e-05	0.000175	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—hematologic cancer	4.91e-05	0.000173	CbGpPWpGaD
Tranexamic Acid—Dizziness—Doxorubicin—hematologic cancer	4.9e-05	9.36e-05	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CCL2—hematologic cancer	4.86e-05	0.000171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6R—hematologic cancer	4.85e-05	0.000171	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CREBBP—hematologic cancer	4.84e-05	0.000171	CbGpPWpGaD
Tranexamic Acid—Nausea—Epirubicin—hematologic cancer	4.76e-05	9.09e-05	CcSEcCtD
Tranexamic Acid—Vomiting—Doxorubicin—hematologic cancer	4.71e-05	9e-05	CcSEcCtD
Tranexamic Acid—Headache—Doxorubicin—hematologic cancer	4.64e-05	8.87e-05	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—MAP2K1—hematologic cancer	4.62e-05	0.000163	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CD—hematologic cancer	4.59e-05	0.000162	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—hematologic cancer	4.4e-05	8.41e-05	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FGF2—hematologic cancer	4.39e-05	0.000155	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3R1—hematologic cancer	4.33e-05	0.000153	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JAK2—hematologic cancer	4.21e-05	0.000148	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MDM2—hematologic cancer	4.11e-05	0.000145	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CB—hematologic cancer	4e-05	0.000141	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTOR—hematologic cancer	4e-05	0.000141	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—hematologic cancer	3.75e-05	0.000132	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP3—hematologic cancer	3.68e-05	0.00013	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—hematologic cancer	3.67e-05	0.000129	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—hematologic cancer	3.58e-05	0.000126	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUN—hematologic cancer	3.57e-05	0.000126	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1A—hematologic cancer	3.46e-05	0.000122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—hematologic cancer	3.46e-05	0.000122	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK8—hematologic cancer	3.38e-05	0.000119	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EP300—hematologic cancer	3.3e-05	0.000116	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SRC—hematologic cancer	3.2e-05	0.000113	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—hematologic cancer	3.12e-05	0.00011	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—STAT3—hematologic cancer	3.09e-05	0.000109	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—NRAS—hematologic cancer	3.08e-05	0.000109	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—hematologic cancer	2.95e-05	0.000104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—hematologic cancer	2.87e-05	0.000101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—hematologic cancer	2.86e-05	0.000101	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—hematologic cancer	2.65e-05	9.35e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—hematologic cancer	2.44e-05	8.59e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—hematologic cancer	2.36e-05	8.31e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HRAS—hematologic cancer	2.26e-05	7.95e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—hematologic cancer	2.16e-05	7.61e-05	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—AKT1—hematologic cancer	1.99e-05	7.02e-05	CbGpPWpGaD
